Baird lowered the firm’s price target on Intuitive Surgical (ISRG) to $600 from $707 and keeps an Outperform rating on the shares. The firm updated its model and believes the tariff impact is already priced into the shares and notes the company has several levers to neutralize the headwinds.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical downgraded to Hold from Buy at Erste Group on Friday
- Intuitive Surgical downgraded to Hold from Buy at Erste Group
- Intuitive Surgical price target lowered to $605 from $666 at Truist
- Intuitive Surgical Positioned for Growth Amidst Rising Adoption of Robotic Surgeries
- Intuitive Surgical’s Strong Market Position and Technological Advancements Justify Buy Rating